Whether you're in early-stage development or scaling up for commercial production, eXmoor Pharma provides the expertise and flexibility you need. Partner with us to move your therapy forward with confidence.
Industry News
eXmoor appoints Matthew Paterson as first Chief Commercial Officer
Nov 16, 2023
Industry News
eXmoor Pharma completes $35 million Series A to expand cell and gene therapy manufacturing capabilities
May 30, 2023
Industry News
eXmoor Pharma and vaccine developer Imophoron sign process development partnership
Feb 22, 2023
Industry News
eXmoor to present at OBN BioTuesday: ‘A Spotlight on the Latest Research and Innovation In Cell & Gene Therapy’
Feb 21, 2023
Industry News
1
2